Table of Contents
1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Executive Summary
3 Introduction
3.1 Renal Diseases Report Coverage
3.2 Chronic Kidney Disease (Chronic Renal Failure) – Overview
3.3 Kidney Fibrosis – Overview
3.4 Polycystic Kidney Disease – Overview
3.5 End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) – Overview
3.6 GBI Research Report Guidance
4 Therapeutics Development
4.1 Chronic Kidney Disease (Chronic Renal Failure)
4.2 Kidney Fibrosis
4.3 Polycystic Kidney Disease
4.4 End-Stage Kidney Disease (End-Stage Renal Disease or ESRD)
5 Therapeutics Assessment
5.1 Chronic Kidney Disease (Chronic Renal Failure)
5.2 Kidney Fibrosis
5.3 Polycystic Kidney Disease
5.4 End-Stage Kidney Disease (End-Stage Renal Disease or ESRD)
6 Companies Involved in Therapeutics Development
6.1 Chronic Kidney Disease (Chronic Renal Failure)
6.2 Kidney Fibrosis
6.3 Polycystic Kidney Disease
6.4 End-Stage Kidney Disease (End-Stage Renal Disease or ESRD)
7 Dormant Projects
7.1 Chronic Kidney Disease (Chronic Renal Failure)
7.2 Kidney Fibrosis
7.3 Polycystic Kidney Disease
7.4 End-Stage Kidney Disease (End-Stage Renal Disease or ESRD)
8 Discontinued Products
8.1 Chronic Kidney Disease (Chronic Renal Failure)
8.2 Kidney Fibrosis
8.3 Polycystic Kidney Disease
8.4 End-Stage Kidney Disease (End-Stage Renal Disease or ESRD)
9 Product Development Milestones
9.1 Chronic Kidney Disease (Chronic Renal Failure)
9.2 Kidney Fibrosis
9.3 Polycystic Kidney Disease
10 Appendix
10.1 Methodology
10.2 Coverage
10.3 Secondary Research
10.4 Primary Research
10.5 Expert Panel Validation
10.6 Contact Us
10.7 Disclaimer